An open-label, controlled, multi-site, Phase 2 clinical trial to assess the ureagenesis capacity in newborns and infants up to the age of 12 months with neonatal and infantile onset of urea cycle disorders (UCD) using a 15N ammonium chloride tracer compared to newborns and infants without UCD
2023-03-06
عنوان الدراسة
An open-label, controlled, multi-site, Phase 2 clinical trial to assess the ureagenesis capacity in newborns and infants up to the age of 12 months with neonatal and infantile onset of urea cycle disorders (UCD) using a 15N ammonium chloride tracer compared to newborns and infants without UCD
داعم الدراسة
Unicyte AG,Aawasserstrasse 2, 6370 Oberdorf NW, Switzerland
دواء الدراسة
15NH4Cl tracer assay
رقم بروتوكول الدراسة
HLSC-UCD-01
حالة الدراسة
Rejected
موقع الدراسة
King Abdulaziz Medical City NG (Riyadh)
مرحلة الدراسة
2
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.